We've found
3,657 Endocrine
clinical trials
We've found
3,657 Endocrine
clinical trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Determination of the Independent Effects of Beetroot Juice Components, Dietary Nitrate and Antioxidants, on Exercise Tolerance and Health Benefits in Individuals With Obesity
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Amitriptyline in Treating Hypoglycemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Nephrology / Urology, Other Clinical Trial
Updated: 12/31/1969
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
WALK Study: Women's Active Living for Koreans Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Glucose Metabolism Disorders Clinical Trial
Updated: 12/31/1969
Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Metabolic Syndrome X Clinical Trial
Updated: 12/31/1969
Mechanisms of Cerebrovascular Control
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Personalized Treatment in Thyroid Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Hematology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of MyoStrain™ in Clinical Practice
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Celiac Disease Clinical Trial
Updated: 12/31/1969
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Celiac Disease Clinical Trial
Updated: 12/31/1969
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Phenylketonurias Clinical Trial
Updated: 12/31/1969
Nutrition Status of Adults Treated With Pegvaliase
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Diabetes Clinical Trial
Updated: 12/31/1969
Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Association Between Cancer and Sarcoidosis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrine Disease Clinical Trial
Updated: 12/31/1969
Study of Endocrine-Related Conditions and Physiology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology, Other Clinical Trial
Updated: 12/31/1969
Studies of Elevated Parathyroid Activity
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Autoimmune Lymphproliferative Syndrome Clinical Trial
Updated: 12/31/1969
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/2/2010
The Effect of Diet and Exercise in Heart Failure
Status: Enrolling
Updated: 12/2/2010
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Reproductive Clinical Trial
Updated: 7/31/2014
Baselines in Reproductive Disorders
Status: Enrolling
Updated: 7/31/2014
Click here to add this to my saved trials

Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/26/2018
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Status: Enrolling,
Phase
Updated: 4/26/2018
Click here to add this to my saved trials

Endocrinology, Other Clinical Trial
Updated: 12/31/1969
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endometrial Cancer Clinical Trial
Updated: 5/2/2013
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Endometrial Cancer Clinical Trial
Updated: 5/2/2013
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 4/1/2008
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 4/1/2008
Click here to add this to my saved trials

Autoimmune Disease Clinical Trial
Updated: 12/31/1969
Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Kawasaki Disease Clinical Trial
Updated: 4/7/2011
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
Status: Enrolling
Updated: 4/7/2011
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
